Status:
COMPLETED
Gender-based Differences in the Outcome of the Treatment of Persistent Septic Shock With Hydrocortisone
Lead Sponsor:
Alexandria University
Conditions:
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to explore the gender-based differences in the outcomes of treatment with hydrocortisone in critically ill patients with persistent septic shock.
Detailed Description
Because of their pleiotropic effects, corticosteroids are widely used as adjunctive therapy in sepsis for their anti-inflammatory, metabolic, and immune-suppressing actions. Moreover, the treatment be...
Eligibility Criteria
Inclusion
- Adult patients of both sexes with persistent septic shock received hydrocortisone during their intensive care unit (ICU) stay.
Exclusion
- Patients with incomplete data sets.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
621 Patients enrolled
Trial Details
Trial ID
NCT06537180
Start Date
January 1 2023
End Date
August 1 2024
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Alexandria University Hospitals
Alexandria, Egypt